Predicting activatory and inhibitory drug-target interactions based on structural compound representations and genetically perturbed transcriptomes
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Won-Yung | - |
dc.contributor.author | Lee, Choong-Yeol | - |
dc.contributor.author | Kim, Chang-Eop | - |
dc.date.accessioned | 2023-05-30T06:40:09Z | - |
dc.date.available | 2023-05-30T06:40:09Z | - |
dc.date.created | 2023-05-30 | - |
dc.date.issued | 2023-04 | - |
dc.identifier.issn | 1932-6203 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/88008 | - |
dc.description.abstract | A computational approach to identifying drug-target interactions (DTIs) is a credible strategy for accelerating drug development and understanding the mechanisms of action of small molecules. However, current methods to predict DTIs have mainly focused on identifying simple interactions, requiring further experiments to understand mechanism of drug. Here, we propose AI-DTI, a novel method that predicts activatory and inhibitory DTIs by combining the mol2vec and genetically perturbed transcriptomes. We trained the model on large-scale DTIs with MoA and found that our model outperformed a previous model that predicted activatory and inhibitory DTIs. Data augmentation of target feature vectors enabled the model to predict DTIs for a wide druggable targets. Our method achieved substantial performance in an independent dataset where the target was unseen in the training set and a high-throughput screening dataset where positive and negative samples were explicitly defined. Also, our method successfully rediscovered approximately half of the DTIs for drugs used in the treatment of COVID-19. These results indicate that AI-DTI is a practically useful tool for guiding drug discovery processes and generating plausible hypotheses that can reveal unknown mechanisms of drug action. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | PUBLIC LIBRARY SCIENCE | - |
dc.relation.isPartOf | PLOS ONE | - |
dc.title | Predicting activatory and inhibitory drug-target interactions based on structural compound representations and genetically perturbed transcriptomes | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000970555500058 | - |
dc.identifier.doi | 10.1371/journal.pone.0282042 | - |
dc.identifier.bibliographicCitation | PLOS ONE, v.18, no.4 | - |
dc.description.isOpenAccess | Y | - |
dc.identifier.scopusid | 2-s2.0-85152482141 | - |
dc.citation.title | PLOS ONE | - |
dc.citation.volume | 18 | - |
dc.citation.number | 4 | - |
dc.contributor.affiliatedAuthor | Lee, Won-Yung | - |
dc.contributor.affiliatedAuthor | Lee, Choong-Yeol | - |
dc.contributor.affiliatedAuthor | Kim, Chang-Eop | - |
dc.type.docType | Article | - |
dc.relation.journalResearchArea | Science & Technology - Other Topics | - |
dc.relation.journalWebOfScienceCategory | Multidisciplinary Sciences | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.